A detailed history of Uss Investment Management LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Uss Investment Management LTD holds 138,915 shares of EW stock, worth $9.17 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
138,915
Holding current value
$9.17 Million
% of portfolio
0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $11.7 Million - $13.1 Million
138,915 New
138,915 $12.8 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $740,520 - $933,120
-12,000 Reduced 9.19%
118,594 $9.04 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $142,786 - $192,456
2,061 Added 1.6%
130,594 $9.05 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $10.5 Million - $12.1 Million
128,533 New
128,533 $12.1 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $105,318 - $134,832
1,542 Added 1.35%
115,997 $8.65 Million
Q3 2022

Nov 08, 2022

SELL
$82.37 - $107.29 $3.21 Million - $4.18 Million
-38,984 Reduced 25.41%
114,455 $9.47 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $642,954 - $953,430
-7,433 Reduced 4.62%
153,439 $14.6 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $1.12 Million - $1.4 Million
10,947 Added 7.3%
160,872 $18.9 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $10.2 Million - $12.1 Million
98,907 Added 193.87%
149,925 $17 Million
Q2 2021

Aug 10, 2021

BUY
$83.84 - $104.76 $4.28 Million - $5.34 Million
51,018 New
51,018 $5.29 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $4.01 Million - $4.63 Million
-51,018 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$67.19 - $87.44 $131,558 - $171,207
1,958 Added 3.99%
51,018 $4.07 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $2.82 Million - $3.78 Million
49,060 New
49,060 $3.39 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.